Table 3 NP distribution represented as area-under-the-curve (AUC) (MFI-μm) for each spheroid (LO or HD) and tumor cell type, relative to NP treatment group
Area under the curve (AUC) | ||||
|---|---|---|---|---|
Cell line | Unmodified NPs | MPG NPs | PEG NPs | Co-treatment NPs |
HeLa | LO [6827 ± 3101] HD [15,841 ± 1637] | LO [14,339 ± 5129] HD [47,018 ± 8754] | LO [4042 ± 2101] HD [23,140 ± 5531] | LO [17,536 ± 2675] HD [15,657 ± 3579] |
CaSki | LO [12,043 ± 5846] HD [9331 ± 1090] | LO [10,847 ± 2673] HD [12,364 ± 1485] | LO [6718 ± 1065] HD [14,297 ± 281] | LO [10,138 ± 2413] HD [11,847 ± 2231] |
SiHa | LO [9377 ± 5219] HD [14,673 ± 543] | LO [10,186 ± 2887] HD [24,972 ± 2020] | LO [18,972 ± 1065] HD [24,237 ± 2532] | LO [19,783 ± 1685] HD [26,970 ± 5574] |